Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and achievement of remission.

If the results from the clinical development plans are positive, it may well reflect a paradigm shift for clinical care.

AbbVie has already paid the Belgian biotech $175 million to ... is possible,” he added. Anti-drug antibodies were produced at similar levels to Humira, but with no impact on safety and ...

UK biotech Bicycle Therapeutics has raised £ ... These are designed to have the affinity and selective pharmacology of antibodies, the distribution kinetics of small molecules, (allowing rapid ...

such as infliximab and adalimumab[3]. The presence of these antibodies is associated with reduced drug efficacy and can complicate treatment decisions. Recent research has highlighted the ...

Guggenheim Securities adjusted its financial outlook for shares of AbbVie Inc . (NYSE:ABBV), reducing the price target to $212 from the previous $221, while still recommending a Buy rating for the ...

through the use of monoclonal antibodies.The Board of Directors of Cadila Healthcare and Carnation Nutra-Analogue Foods Ltd. at their respective meeting held on 4 July 2008 approved the modalities ...